38112003: un (valeur de l'attribut)

SNOMED CT Concept\valeur de l'attribut\nombre\un

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
un	est un(e) (attribut)	modificateur adjectival général	false	Inferred relationship	Some
un	est un(e) (attribut)	nombre	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Venetoclax 10 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Venetoclax 10 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Venetoclax 50 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Venetoclax 50 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Venetoclax 100 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Venetoclax 100 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely avelumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely avelumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely ivosidenib 250 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely ivosidenib 250 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely pembrolizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely pembrolizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only radium-223 (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Radium-223 only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely teduglutide 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely teduglutide 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only midazolam in nasal dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only alpelisib (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Alpelisib only product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Alpelisib 50 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Alpelisib 50 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely alpelisib 150 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely alpelisib 150 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely alpelisib 200 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely alpelisib 200 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing only polatuzumab vedotin (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Polatuzumab vedotin only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Bremelanotide only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Bremelanotide only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only onabotulinumtoxinA (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
OnabotulinumtoxinA only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely onabotulinumtoxinA 200 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely onabotulinumtoxinA 200 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
OnabotulinumtoxinA 100 unit lyophilized powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
OnabotulinumtoxinA 100 unit lyophilized powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing only selinexor (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Selinexor only product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Gadobutrol only product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Nitrous oxide only product in pulmonary dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Glucagon only product in nasal dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Glucose 50 mg/mL and sodium chloride 9 mg/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Glucose 50 mg/mL and sodium chloride 9 mg/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	2
Apremilast only product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely apremilast 20 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely apremilast 20 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Apremilast 10 mg oral tablet	Count of base of active ingredient	False	un	Inferred relationship	Some
Apremilast 10 mg oral tablet	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely apremilast 30 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely apremilast 30 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only darolutamide (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only darolutamide in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection	Count of base of active ingredient	False	un	Inferred relationship	Some
Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial	Count of base of active ingredient	False	un	Inferred relationship	Some
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen	Count of base of active ingredient	False	un	Inferred relationship	Some
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen	Count of base of active ingredient	False	un	Inferred relationship	Some
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen	Count of base of active ingredient	False	un	Inferred relationship	Some
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen	Count of base of active ingredient	False	un	Inferred relationship	Some
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Pexidartinib only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only pexidartinib in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely albumin human 250 milligram/1 milliliter conventional release solution for infusion (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely albumin human 250 milligram/1 milliliter conventional release solution for infusion (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing only albumin human (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Albumin human only product in parenteral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Albumin human 50 mg/mL solution for infusion	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Albumin human 50 mg/mL solution for infusion	Count of base of active ingredient	False	un	Inferred relationship	Some
Albumin human 45 mg/mL solution for infusion	Count of base of active ingredient	False	un	Inferred relationship	Some
Albumin human 45 mg/mL solution for infusion	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely albumin human 200 milligram/1 milliliter conventional release solution for infusion (clinical drug)	Has concentration strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely albumin human 200 milligram/1 milliliter conventional release solution for infusion (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Pretomanid only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only pretomanid in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing precisely crisantaspase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	un	Inferred relationship	Some	1
Product containing precisely crisantaspase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	un	Inferred relationship	Some
Pitolisant only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only pitolisant in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only entrectinib (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only entrectinib in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Fedratinib only product	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only fedratinib in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Tegaserod only product in oral dose form	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only liraglutide in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only upadacitinib (medicinal product)	Count of base of active ingredient	False	un	Inferred relationship	Some
Product containing only upadacitinib in oral dose form (medicinal product form)	Count of base of active ingredient	False	un	Inferred relationship	Some

Start Previous Page 105 of 217 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
33081000077110	un	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
615211000077111	un (valeur de l'attribut)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
771016011	One (qualifier value)	en	Fully specified name	Inactive	Only initial character case insensitive (core metadata concept)	SNOMED CT core